NO20023892D0 - Anvendelse av en forbindelse for fremstilling av et medikament - Google Patents

Anvendelse av en forbindelse for fremstilling av et medikament

Info

Publication number
NO20023892D0
NO20023892D0 NO20023892A NO20023892A NO20023892D0 NO 20023892 D0 NO20023892 D0 NO 20023892D0 NO 20023892 A NO20023892 A NO 20023892A NO 20023892 A NO20023892 A NO 20023892A NO 20023892 D0 NO20023892 D0 NO 20023892D0
Authority
NO
Norway
Prior art keywords
group
lower alkyl
iodine
compound
carbon atoms
Prior art date
Application number
NO20023892A
Other languages
English (en)
Other versions
NO323783B1 (no
NO20023892L (no
Inventor
Lennart Moeller
Jan Olof Bergman
Original Assignee
Lundblad Leif J I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundblad Leif J I filed Critical Lundblad Leif J I
Publication of NO20023892L publication Critical patent/NO20023892L/no
Publication of NO20023892D0 publication Critical patent/NO20023892D0/no
Publication of NO323783B1 publication Critical patent/NO323783B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20023892A 2000-02-18 2002-08-16 Anvendelse av en forbindelse for fremstilling av et medikament NO323783B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel
PCT/SE2001/000326 WO2001060371A1 (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug

Publications (3)

Publication Number Publication Date
NO20023892L NO20023892L (no) 2002-08-16
NO20023892D0 true NO20023892D0 (no) 2002-08-16
NO323783B1 NO323783B1 (no) 2007-07-09

Family

ID=20278504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023892A NO323783B1 (no) 2000-02-18 2002-08-16 Anvendelse av en forbindelse for fremstilling av et medikament

Country Status (14)

Country Link
EP (1) EP1261344B1 (no)
JP (1) JP2003522792A (no)
CN (1) CN1192777C (no)
AT (1) ATE269083T1 (no)
AU (2) AU3626601A (no)
CA (1) CA2400236C (no)
DE (1) DE60103857T2 (no)
ES (1) ES2222981T3 (no)
HU (1) HUP0204547A3 (no)
NO (1) NO323783B1 (no)
RU (1) RU2266117C2 (no)
SE (1) SE516067C2 (no)
WO (1) WO2001060371A1 (no)
ZA (1) ZA200206733B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527639C2 (sv) * 2004-06-17 2006-05-02 Oxypharma Ab Alkylsubstituerade indolokinoxaliner
ATE473977T1 (de) 2008-04-30 2010-07-15 Univ Duisburg Essen Indolä2,3-bü-, indenä1,2-bü- und indenä2,1- büpyridoä2,3-fü quinoxalin-3-carboxylsäuren und ester, verfahren zu ihrer herstellung und ihre verwendung als antivirus- und antitumormittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner

Also Published As

Publication number Publication date
DE60103857T2 (de) 2005-07-14
CA2400236A1 (en) 2001-08-23
ZA200206733B (en) 2003-08-22
RU2266117C2 (ru) 2005-12-20
DE60103857D1 (de) 2004-07-22
EP1261344A1 (en) 2002-12-04
AU3626601A (en) 2001-08-27
HUP0204547A2 (hu) 2003-04-28
CN1404393A (zh) 2003-03-19
HUP0204547A3 (en) 2006-01-30
ATE269083T1 (de) 2004-07-15
CA2400236C (en) 2009-09-22
RU2002124771A (ru) 2004-03-10
NO323783B1 (no) 2007-07-09
ES2222981T3 (es) 2005-02-16
EP1261344B1 (en) 2004-06-16
AU2001236266B2 (en) 2005-03-17
WO2001060371A1 (en) 2001-08-23
SE516067C2 (sv) 2001-11-12
SE0000537L (sv) 2001-08-19
JP2003522792A (ja) 2003-07-29
NO20023892L (no) 2002-08-16
SE0000537D0 (sv) 2000-02-18
CN1192777C (zh) 2005-03-16

Similar Documents

Publication Publication Date Title
HUP0002112A2 (hu) Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
HUP0401083A2 (hu) 4-Amino-6-fenil-pirrolo[2,3-d]pirimidin-származékok, ezeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
NZ506574A (en) Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism
HUP0101031A2 (hu) Biciklo[2.2.1]heptán-származékok és rokon vegyületek
NZ518144A (en) Piperazine Compounds
HUP9904703A2 (hu) Aminotiofén-karbonsav-amidok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
EP0409406A3 (en) Aryl-substituted amine derivatives useful in cancer therapy
SE8600260D0 (sv) Substituerade indolokinoxaliner
MY117783A (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
HUT46313A (en) Process for producing 3/2h/-pyridazine derivatives and pharmaceutical compositions containing them as active components
JPS55133362A (en) Diphenylhydantoin derivative*medical drug containing it and its manufacture
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
NO20023892D0 (no) Anvendelse av en forbindelse for fremstilling av et medikament
MXPA04005077A (es) Derivados de benzotiazol.
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
HUP0003861A2 (hu) Kinolin-4-il-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
GR3023373T3 (en) Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
MY141374A (en) Water soluble camptothecin derivatives
BG102658A (en) Derivatives of condensed 2,3-benzodiazepines and their use as ampa-receptor inhibitors
MXPA04002838A (es) Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
IL112344A (en) Pharmaceutical compositions comprising 7, 9, 9-trisubstituted- 3-benzoyl-3, 7-diazabicyclo £3.3.1| nonanes for the treatment of cardiac arrhythmias
SE9900677D0 (sv) Agent for use in transplantation

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees